Unlike traditional PCR tests, Rhea molecular diagnostic tests need no lab equipment, allowing them to be used directly in the field.
The first panel test in the new range is Rhéa Vector-Borne Diseases, which simultaneously detects four major pathogens in under 40 minutes: Theileria spp., Babesia spp., Anaplasma spp. (including A. marginale and A. phagocytophilum), and Borrelia spp.
Enalees says the Rhéa range addresses a growing need in the sector, enabling vets to act quickly and accurately.
https://www.enalees.com
Enalees offers a variety of point-of-care isothermal PCR animal diagnostics tests for canine, feline and equine infectious diseases, including parvo, leptospirosis, babesiosis and borreliosis.
The company says its tests are highly specific and sensitive and can detect the presence of a virus, parasite or microbe at a very early stage, without the use of expensive and complex equipment, within 30 minutes.
Lauren Craig is the General Manager of the new subsidiary. She said: “I will be coordinating the launch of the UK subsidiary and working with veterinary professionals to deliver Enalees’ unique portfolio offering in diagnostic testing and in clinic rapid PCR tests.
“I am incredibly excited for the challenge ahead and looking forward to working with a fantastic team with an important mission in this key market.”
www.enalees.com